Oligodendrocytes in Alzheimer's Disease Pathophysiology

Overview

Journal Nat Neurosci

Date 2025 Jan 29

PMID 39881195

Authors

Shreeya Kedia

Mikael Simons

Affiliations

Soon will be listed here.

Abstract

Our understanding of Alzheimer's disease (AD) has transformed from a purely neuronal perspective to one that acknowledges the involvement of glial cells. Despite remarkable progress in unraveling the biology of microglia, astrocytes and vascular elements, the exploration of oligodendrocytes in AD is still in its early stages. Contrary to the traditional notion of oligodendrocytes as passive bystanders in AD pathology, emerging evidence indicates their active participation in and reaction to amyloid and tau pathology. Oligodendrocytes undergo a functional transition to a disease-associated state, engaging in immune modulation, stress responses and cellular survival. Far from being inert players, they appear to serve a dual role in AD pathogenesis, potentially offering defense mechanisms against pathology while also contributing to disease progression. This Review explores recent advancements in understanding the roles of oligodendrocytes and their myelin sheaths in the context of AD, shedding light on their complex interactions within the disease pathology.

References

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View

Selkoe D, Hardy J . The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016; 8(6):595-608. PMC: 4888851. DOI: 10.15252/emmm.201606210. View

Jack Jr C, Knopman D, Jagust W, Petersen R, Weiner M, Aisen P . Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013; 12(2):207-16. PMC: 3622225. DOI: 10.1016/S1474-4422(12)70291-0. View

Frisoni G, Altomare D, Thal D, Ribaldi F, van der Kant R, Ossenkoppele R . The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2021; 23(1):53-66. PMC: 8840505. DOI: 10.1038/s41583-021-00533-w. View

Rollo J, Crawford J, Hardy J . A dynamical systems approach for multiscale synthesis of Alzheimer's pathogenesis. Neuron. 2023; 111(14):2126-2139. DOI: 10.1016/j.neuron.2023.04.018. View

Simons M, Levin J, Dichgans M . Tipping points in neurodegeneration. Neuron. 2023; 111(19):2954-2968. DOI: 10.1016/j.neuron.2023.05.031. View

De Strooper B, Karran E . The Cellular Phase of Alzheimer's Disease. Cell. 2016; 164(4):603-15. DOI: 10.1016/j.cell.2015.12.056. View

Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young J . Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019; 570(7761):332-337. PMC: 6865822. DOI: 10.1038/s41586-019-1195-2. View

Mathys H, Peng Z, Boix C, Victor M, Leary N, Babu S . Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer's disease pathology. Cell. 2023; 186(20):4365-4385.e27. PMC: 10601493. DOI: 10.1016/j.cell.2023.08.039. View

10.

Stadelmann C, Timmler S, Barrantes-Freer A, Simons M . Myelin in the Central Nervous System: Structure, Function, and Pathology. Physiol Rev. 2019; 99(3):1381-1431. DOI: 10.1152/physrev.00031.2018. View

11.

Marques S, Zeisel A, Codeluppi S, van Bruggen D, Falcao A, Xiao L . Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science. 2016; 352(6291):1326-1329. PMC: 5221728. DOI: 10.1126/science.aaf6463. View

12.

Falcao A, van Bruggen D, Marques S, Meijer M, Jakel S, Agirre E . Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat Med. 2018; 24(12):1837-1844. PMC: 6544508. DOI: 10.1038/s41591-018-0236-y. View

13.

Timmler S, Simons M . Grey matter myelination. Glia. 2019; 67(11):2063-2070. DOI: 10.1002/glia.23614. View

14.

Hughes E, Orthmann-Murphy J, Langseth A, Bergles D . Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex. Nat Neurosci. 2018; 21(5):696-706. PMC: 5920726. DOI: 10.1038/s41593-018-0121-5. View

15.

Simons M, Misgeld T, Kerschensteiner M . A unified cell biological perspective on axon-myelin injury. J Cell Biol. 2014; 206(3):335-45. PMC: 4121977. DOI: 10.1083/jcb.201404154. View

16.

Bergles D, Roberts J, Somogyi P, Jahr C . Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature. 2000; 405(6783):187-91. DOI: 10.1038/35012083. View

17.

Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F . Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci U S A. 1996; 93(18):9887-92. PMC: 38524. DOI: 10.1073/pnas.93.18.9887. View

18.

Gibson E, Purger D, Mount C, Goldstein A, Lin G, Wood L . Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science. 2014; 344(6183):1252304. PMC: 4096908. DOI: 10.1126/science.1252304. View

19.

Paez P, Lyons D . Calcium Signaling in the Oligodendrocyte Lineage: Regulators and Consequences. Annu Rev Neurosci. 2020; 43:163-186. DOI: 10.1146/annurev-neuro-100719-093305. View

20.

Chen T, Kula B, Nagy B, Barzan R, Gall A, Ehrlich I . In Vivo Regulation of Oligodendrocyte Precursor Cell Proliferation and Differentiation by the AMPA-Receptor Subunit GluA2. Cell Rep. 2018; 25(4):852-861.e7. DOI: 10.1016/j.celrep.2018.09.066. View